Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.970 +0.180 (+2.31%)
Streaming Delayed Price Updated: 10:16 AM EDT, Apr 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Cramer Warns Investor To Avoid This Entire Industry: 'I Do Not Want You To Touch Any Of These Stocks' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Everbridge Inc (NASDAQ: EVBG) as it does not make money. 
Via Benzinga
News headline image
Peering Into Ginkgo Bioworks Holdings's Recent Short Interest ↗
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 24.11% since its last report. The company recently reported that it has 179.06 million shares sold short... 
Via Benzinga
News headline image
5 Top Stocks Cathie Wood Is Buying This Week ↗
Cathie Wood's Ark Invest had an active week of buying shares in companies like DKNG and TDOC. Investors are intrigued by Cathie Wood stocks. 
Via InvestorPlace
News headline image
Don’t Jump Into the Deepening Financial Hole with Ginkgo Bioworks ↗
You don't have to mimic Wood's trades, as DNA stock could continue its downward trajectory due to Ginkgo Bioworks' imperfect financials. 
Via InvestorPlace
News headline image
5 Cathie Wood Stocks Signaling “The Bear Market Is Over” ↗
These top Cathie Wood stocks are signalling that the bear market is over. For savvy investors, that presents a chance to profit. 
Via InvestorPlace
News headline image
Cathie Wood Favorite Ginkgo Bioworks Bolsters Biosecurity Platform Via This Acquisition ↗
 
Via Benzinga
News headline image
Wayfair, Bed Bath & Beyond And Other Big Losers From Friday ↗
U.S. stocks closed lower with the Nasdaq Composite dropping 260 points on Friday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
News headline image
Cathie Wood Is Doubling Down on Ginkgo Bioworks (DNA) Stock ↗
Notorious ARK Fund Manager Cathie Wood has continued her investment into Ginkgo Bioworks this week. Despite this, DNA stock is down today. 
Via InvestorPlace
News headline image
Walmart, Gap, Nordstrom And Some Other Big Stocks Recording Gains On Tuesday ↗
U.S. stocks closed mostly higher on Tuesday, with the Dow Jones gaining around 240 points. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday ↗
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. 
Via Benzinga
News headline image
Why Is FuboTV (FUBO) Stock Up 55% Today? ↗
FuboTV (FUBO) stock is rising higher on Tuesday after the company announced an update to its leadership team. 
Via InvestorPlace
News headline image
What Is Going on With Ginkgo Bioworks (DNA) Stock Today? ↗
Ginkgo Bioworks is trending today after crushing its Q2 earnings call this morning. DNA stock is up more than 10% on strong revenue growth. 
Via InvestorPlace
News headline image
Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales. 
Via Benzinga
News headline image
Raymond James Maintains Outperform Rating for Ginkgo Bioworks Holdings: Here's What You Need To Know ↗
  Raymond James has decided to maintain its Outperform rating of Ginkgo Bioworks Holdings (NYSE:DNA) and raise its price target from $11.50 to $14.50. Shares of Ginkgo Bioworks Holdings are trading up... 
Via Benzinga
News headline image
Why Ginkgo Bioworks Stock Is Soaring Today ↗
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Tuesday after the company reported strong financial results and raised full-year guidance above analyst estimates. 
Via Benzinga
News headline image
Nu Holdings, Ally Financial And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares rose 17.5% to $4.10 in pre-market trading after the company said Q2 sales results were up year over year and raised FY22 sales guidance above... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time for an overview of the biggest pre-market stock movers for Tuesday and the news that's affecting them this morning. 
Via InvestorPlace
News headline image
Why IZEA Worldwide Shares Are Trading Higher By Over 30%: Here Are 37 Stocks Moving Premarket ↗
Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) shares rose 30.8% to $1.19 in pre-market trading after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million,... 
Via Benzinga
News headline image
Why Cathie Wood Favorite Ginkgo Bioworks Is Surging After Hours ↗
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher in Monday's after-hours session after the company reported strong financial results and raised full-year guidance above analy 
Via Benzinga
News headline image
Looking Into Ginkgo Bioworks Holdings Recent Short Interest ↗
Ginkgo Bioworks Holdings (NYSE:DNA) short percent of float has risen 3.5% since its last report. The company recently reported that it has 150.27 million shares sold... 
Via Benzinga
News headline image
An Airport Spa And Biosecurity Co. Act As "Surveillance" In US Airports As Part Of $60M CDC "Early Warning" Contract For SARS-CoV-2 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 15, 2022 ↗
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
SmileDirectClub (SDC) Stock Gains Despite Weak Q2 Earnings ↗
SmileDirectClub (SDC) stock is on the move Friday following the release of its earnings report for the second quarter of 2022. 
Via InvestorPlace
News headline image
What Is Going on With Ginkgo Bioworks (DNA) Stock Today? ↗
DNA stock and other small biotech plays are rising on speculation about drugs like its candidate against gout. 
Via InvestorPlace
News headline image
Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket ↗
Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange. 
Via Benzinga
News headline image
What Is Going on With 23andMe (ME) Stock Today? ↗
23andMe, Invitae and others are seeing an explosive rally, but investors want to know if ME stock and others can continue to climb. 
Via InvestorPlace
News headline image
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday ↗
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. 
Via Benzinga
News headline image
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering. 
Via Benzinga
News headline image
Dow Eyes Another Triple-Digit Win As Sentiment Turns Sunny ↗
Stocks are eyeing even more upside this Thursday afternoon. 
Via Talk Markets
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.